General Atlantic

Latest statistics and disclosures from General Atlantic's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by General Atlantic consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for General Atlantic

General Atlantic holds 12 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Liftoff Mobile 20.9 $608M NEW 25M 24.02
 View chart
Dlocal Cl A (DLO) 20.9 $606M 47M 12.99
 View chart
Chime Com Shs Cl A (CHYM) 15.0 $435M 21M 20.48
 View chart
Alkami Technology (ALKT) 12.1 $351M +26% 19M 18.12
 View chart
XP Cl A (XP) 11.5 $334M 21M 16.26
 View chart
Pharvaris N V (PHVS) 7.8 $227M -18% 6.6M 34.58
 View chart
Seaport Therapeutics 4.6 $133M NEW 6.1M 21.72
 View chart
Nurix Therapeutics (NRIX) 2.5 $74M -26% 3.0M 24.26
 View chart
Revolution Medicines (RVMD) 2.3 $67M -49% 358k 187.28
 View chart
Parabilis Medicines 1.4 $42M NEW 1.5M 27.37
 View chart
Riskified Cl A (RSKD) 0.9 $27M 5.3M 5.04
 View chart
Grove Collaborative Cl A (GROV) 0.1 $3.1M 2.5M 1.25
 View chart

Past Filings by General Atlantic

SEC 13F filings are viewable for General Atlantic going back to 2010

View all past filings